Semi-Annual Statement Of Income And Retained Earnings

Delta-Fly Pharma, Inc. - Filing #7591826

Concept 2022-04-01 to
2022-06-30
2021-04-01 to
2021-06-30
Semi-annual statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
-304,263,000 JPY
-304,764,000 JPY
Non-operating income
Non-operating income
0 JPY
484,000 JPY
Non-operating expenses
Non-operating expenses
3,589,000 JPY
1,879,000 JPY
Ordinary profit (loss)
-307,853,000 JPY
-306,159,000 JPY
Profit (loss) before income taxes
-307,853,000 JPY
-306,159,000 JPY
Income taxes - current
812,000 JPY
804,000 JPY
Profit (loss)
-308,666,000 JPY
-306,963,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.